04/26/2024
8:39 AM | Titan Pharmaceuticals (Filer)
| Form RW | |
04/05/2024
3:34 PM | Sire Group Ltd. (Filed by)
Titan Pharmaceuticals (Subject)
| Form SC 13D/A | |
04/05/2024
9:13 AM | Flores Francisco (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/05/2024
9:14 AM | Mokhtar Firdauz (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
8:45 AM | Choong Choon Hau (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
11:19 AM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/18/2024
3:59 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
01/08/2024
4:13 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2023
3:30 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2023
3:30 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2023
3:05 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2023
3:15 PM | Titan Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/26/2023
3:23 PM | Ben-Tzvi Avraham (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/26/2023
3:25 PM | Beebe Katherine (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/26/2023
3:29 PM | Greenberg Eric Howard (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/26/2023
3:31 PM | McMurdo Matthew Charles (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/26/2023
3:33 PM | NATAN DAVID (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2023
4:26 PM | Titan Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/23/2023
2:07 PM | Chiam Brynner (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/16/2023
4:08 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
4:30 PM | Sire Group Ltd. (Filed by)
Titan Pharmaceuticals (Subject)
| Form SC 13D | |
10/04/2023
3:40 PM | Shen Seow Gim (Reporting)
Sire Group Ltd. (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/19/2023
3:41 PM | Titan Pharmaceuticals (Filer)
| Form 8-K/A | |
09/18/2023
3:45 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/08/2023
4:30 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2023
3:28 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
4:08 PM | Titan Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2023
7:06 PM | Greenberg Eric Howard (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2023
6:42 PM | McMurdo Matthew Charles (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4/A | |
07/31/2023
6:44 PM | Chasey Peter Louis (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4/A | |
07/31/2023
6:45 PM | NATAN DAVID (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4/A | |
07/31/2023
6:38 PM | Ben-Tzvi Avraham (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2023
6:39 PM | Lazar David E. (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2023
4:42 PM | NATAN DAVID (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2023
4:43 PM | McMurdo Matthew Charles (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2023
4:45 PM | Beebe Katherine (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2023
4:47 PM | Chasey Peter Louis (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/20/2023
8:57 PM | Choong Choon Hau (Filed by)
Titan Pharmaceuticals (Subject)
| Form SC 13D | |
07/20/2023
8:57 PM | Choong Choon Hau (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/07/2023
9:28 AM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
3:15 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Gold Mania (Ad) Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential
He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite). See his free reveal right here. |
06/23/2023
4:28 PM | Titan Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
06/23/2023
3:05 PM | Activist Investing LLC (Filed by)
Titan Pharmaceuticals (Subject)
| Form SC 13D/A | |
06/23/2023
3:07 PM | Activist Investing LLC (Reporting)
Lazar David E. (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
9:17 AM | Titan Pharmaceuticals (Filer)
| Form ARS | |
05/19/2023
8:30 AM | Titan Pharmaceuticals (Filer)
| Form DEFA14A | |
05/19/2023
8:22 AM | Titan Pharmaceuticals (Filer)
| Form DEF 14A | |
